1. Home
  2. TGL vs DRMA Comparison

TGL vs DRMA Comparison

Compare TGL & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treasure Global Inc.

TGL

Treasure Global Inc.

HOLD

Current Price

$2.13

Market Cap

5.4M

Sector

Technology

ML Signal

HOLD

Logo Dermata Therapeutics Inc.

DRMA

Dermata Therapeutics Inc.

HOLD

Current Price

$1.16

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGL
DRMA
Founded
2020
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4M
5.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
TGL
DRMA
Price
$2.13
$1.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 142.7K
33.1K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,330,557.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$650.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.26
$0.95
52 Week High
$58.00
$5.87

Technical Indicators

Market Signals
Indicator
TGL
DRMA
Relative Strength Index (RSI) 42.38 42.03
Support Level $2.04 $1.11
Resistance Level $3.30 $1.40
Average True Range (ATR) 0.37 0.08
MACD -0.06 -0.00
Stochastic Oscillator 9.27 35.76

Price Performance

Historical Comparison
TGL
DRMA

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.

Share on Social Networks: